You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Novel platform leveraging electronic medical record (EMR) to triage patients admitted with high-grade immune-related adverse events (irAEs) to the immune-toxicity (ITOX) service

Citation Tools

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Novel platform leveraging electronic medical record (EMR) to triage patients admitted with high-grade immune-related adverse events (irAEs) to the immune-toxicity (ITOX) service

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Abu-Shawer O, Singh P, Yenulevich E, et al
Novel platform leveraging electronic medical record (EMR) to triage patients admitted with high-grade immune-related adverse events (irAEs) to the immune-toxicity (ITOX) service
Journal for ImmunoTherapy of Cancer 2020;8:e000992. doi: 10.1136/jitc-2020-000992